GB1568837A - Controlled release tablet - Google Patents

Controlled release tablet Download PDF

Info

Publication number
GB1568837A
GB1568837A GB41121/76A GB4112176A GB1568837A GB 1568837 A GB1568837 A GB 1568837A GB 41121/76 A GB41121/76 A GB 41121/76A GB 4112176 A GB4112176 A GB 4112176A GB 1568837 A GB1568837 A GB 1568837A
Authority
GB
United Kingdom
Prior art keywords
tablet
polymer
water
cellulose
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB41121/76A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of GB1568837A publication Critical patent/GB1568837A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
GB41121/76A 1975-10-10 1976-10-04 Controlled release tablet Expired GB1568837A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62131675A 1975-10-10 1975-10-10

Publications (1)

Publication Number Publication Date
GB1568837A true GB1568837A (en) 1980-06-04

Family

ID=24489671

Family Applications (1)

Application Number Title Priority Date Filing Date
GB41121/76A Expired GB1568837A (en) 1975-10-10 1976-10-04 Controlled release tablet

Country Status (16)

Country Link
JP (1) JPS5264420A (enExample)
AU (1) AU516051B2 (enExample)
BE (1) BE847095A (enExample)
CA (1) CA1097220A (enExample)
CH (1) CH616843A5 (enExample)
DE (1) DE2645547A1 (enExample)
DK (1) DK454876A (enExample)
FR (1) FR2326933A1 (enExample)
GB (1) GB1568837A (enExample)
HU (1) HU175540B (enExample)
IE (1) IE44540B1 (enExample)
NL (1) NL7611148A (enExample)
NO (1) NO763450L (enExample)
PH (1) PH14564A (enExample)
SE (1) SE435569B (enExample)
ZA (1) ZA765931B (enExample)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0094117A3 (en) * 1982-05-06 1984-08-01 The Procter & Gamble Company Therapeutic granules
GB2151921A (en) * 1983-12-21 1985-07-31 Rhone Poulenc Sante Controlled release form of ketoprofen for oral administration
US4816264A (en) * 1986-06-06 1989-03-28 Warner-Lambert Company Sustained release formulations
EP0403383A1 (en) * 1989-06-16 1990-12-19 Rhone-Poulenc Sante Sustained release pharmaceutical formulations
US5196203A (en) * 1989-01-06 1993-03-23 F. H. Faulding & Co. Limited Theophylline dosage form
US5202128A (en) * 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
US5234691A (en) * 1989-10-27 1993-08-10 Sumitomo Pharmaceuticals Co., Ltd. Sustained-release prepararation of basic medical agent hydrochloride
US5277916A (en) * 1988-02-01 1994-01-11 F. H. Faulding & Co., Ltd. Tetracycline dosage form
EP0941064A4 (en) * 1996-11-17 2001-12-12 Yissum Res Dev Co MEDICINES FOR CONTROLLED RELEASE OF Lactam Beta Antibiotics

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU806037A1 (ru) * 1978-04-06 1981-02-23 Всесоюзный Кардиологический Научныйцентр Amh Cccp Антиангинальное средство
JPS5626810A (en) * 1979-08-06 1981-03-16 Kurishiyuna Mitora Arun Antiacid delivering form controlled and treating method using said form
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
AU1873783A (en) * 1982-10-08 1984-04-12 Verex Laboratories Inc. Constant release formulation
JPS6051106A (ja) * 1983-08-31 1985-03-22 Yamanouchi Pharmaceut Co Ltd 塩酸アモスラロ−ル持続性製剤
HU190619B (en) 1983-11-11 1986-09-29 Bezzegh,Denes,Hu Process for producing tablets with controlled dissolution of active ingredients
DE3448522C2 (de) * 1983-11-11 1995-08-24 Egyt Gyogyszervegyeszeti Gyar Pharmazeutische Präparate, insbesondere Tabletten, mit geregelter beziehungsweise verzögerter Wirkstoffabgabe, sowie Verfahren zur Herstellung derselben
DE3420666A1 (de) 1984-06-02 1985-12-05 Mannesmann Rexroth GmbH, 8770 Lohr Niveauregeleinrichtung fuer fahrzeuge mit mindestens einem hydraulischen schwingungsdaempfer
US4673527A (en) * 1985-05-20 1987-06-16 Autotrol Corporation Tablet granulation
JPH0667828B2 (ja) * 1985-10-09 1994-08-31 日研化学株式会社 バルプロ酸ナトリウムの持続性顆粒製剤
IE59540B1 (en) * 1987-01-09 1994-03-09 Elan Corp Sustained release capsule or tablet formulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2887440A (en) * 1957-08-12 1959-05-19 Dow Chemical Co Enteric coating
US3458622A (en) * 1967-04-07 1969-07-29 Squibb & Sons Inc Controlled release tablet

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0094117A3 (en) * 1982-05-06 1984-08-01 The Procter & Gamble Company Therapeutic granules
GB2151921A (en) * 1983-12-21 1985-07-31 Rhone Poulenc Sante Controlled release form of ketoprofen for oral administration
US4816264A (en) * 1986-06-06 1989-03-28 Warner-Lambert Company Sustained release formulations
US5277916A (en) * 1988-02-01 1994-01-11 F. H. Faulding & Co., Ltd. Tetracycline dosage form
US5196203A (en) * 1989-01-06 1993-03-23 F. H. Faulding & Co. Limited Theophylline dosage form
US5202128A (en) * 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
EP0403383A1 (en) * 1989-06-16 1990-12-19 Rhone-Poulenc Sante Sustained release pharmaceutical formulations
US5234691A (en) * 1989-10-27 1993-08-10 Sumitomo Pharmaceuticals Co., Ltd. Sustained-release prepararation of basic medical agent hydrochloride
EP0941064A4 (en) * 1996-11-17 2001-12-12 Yissum Res Dev Co MEDICINES FOR CONTROLLED RELEASE OF Lactam Beta Antibiotics
US6399086B1 (en) 1996-11-17 2002-06-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Pharmaceutical preparations for the controlled release of beta-lactam antibiotics

Also Published As

Publication number Publication date
IE44540B1 (en) 1981-12-30
PH14564A (en) 1981-09-24
NO763450L (enExample) 1977-04-13
JPS5264420A (en) 1977-05-27
SE435569B (sv) 1984-10-08
NL7611148A (nl) 1977-04-13
DK454876A (da) 1977-04-11
CH616843A5 (en) 1980-04-30
AU1844676A (en) 1978-04-13
AU516051B2 (en) 1981-05-14
ZA765931B (en) 1977-09-28
SE7611241L (sv) 1977-04-11
DE2645547A1 (de) 1977-04-14
FR2326933B1 (enExample) 1979-03-02
HU175540B (hu) 1980-08-28
FR2326933A1 (fr) 1977-05-06
CA1097220A (en) 1981-03-10
IE44540L (en) 1977-04-10
BE847095A (fr) 1977-01-31

Similar Documents

Publication Publication Date Title
US4252786A (en) Controlled release tablet
US4756911A (en) Controlled release formulation
US4610870A (en) Controlled release formulation
GB1568837A (en) Controlled release tablet
US4666705A (en) Controlled release formulation
EP1101489B1 (en) Sustained release heterodisperse hydrogel systems for insoluble drugs
Gazzaniga et al. Oral delayed-release system for colonic specific delivery
US5273758A (en) Directly compressible polyethylene oxide vehicle for preparing therapeutic dosage forms
KR100337985B1 (ko) 아스테미졸및슈도에페드린의서방성필름-코팅정제
AU2002248792B2 (en) A novel coating for a sustained release pharmaceutical composition
US3458622A (en) Controlled release tablet
KR100205276B1 (ko) 서방성 정제
EP0223365B1 (en) Cefuroxime axetil dragee
CA2344372C (en) Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same
JPH11506774A (ja) 予め形成した通路を有する放出性が制御された製剤
AU2002248792A1 (en) A novel coating for a sustained release pharmaceutical composition
AU8561798A (en) Multiple-unit sustained release tablets
US20030099710A1 (en) Granule modulating hydrogel system
EP1487420A1 (en) Coated pharmaceutical single-unit delayed-release forms, based on polyvinyl acetate
US4973470A (en) Sustained release pharmaceutical compositions
EP1589957A1 (en) Pharmaceutical compositions and process of production thereof
WO1993016686A1 (en) Pharmaceutical preparation for sustained release of a drug and process for producing the same
US6726930B1 (en) Sustained release heterodisperse hydrogel systems for insoluble drugs
WO1998003161A1 (en) Controlled release tablets
US20040228918A1 (en) Granule modulating hydrogel system

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee